Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Organic Letters|August 17, 2013
Dinuclear zinc-ProPhenol-catalyzed enantioselective α-hydroxyacetate aldol reaction with activated ester equivalentsBarry M Trost, David J Michaelis, Mihai I TruicaCancer Research|October 22, 2020
Turning Up the Heat on MYC: Progress in Small-Molecule InhibitorsMihai I Truica, Michael C Burns, Huiying Han, et al.Life Science Alliance|December 17, 2020
FIREWORKS: a bottom-up approach to integrative coessentiality network analysisDavid R Amici, Jasen M Jackson, Mihai I Truica, et al.Science Advances|April 27, 2022
A MYC inhibitor selectively alters the MYC and MAX cistromes and modulates the epigenomic landscape to regulate target gene expressionAustin G Holmes, J Brandon Parker, Vinay Sagar, et al.Nature Communications|February 24, 2026
Heterobifunctional proteomimetic polymers for targeted degradation of MYC and KRASMax M Wang, Mihai I Truica, Brayley S Gattis, et al.Biorxiv : the Preprint Server for Biology|March 31, 2025
Heterobifunctional proteomimetic polymers for targeted protein degradationMax M Wang, Mihai I Truica, Brayley S Gattis, et al.Cancer Research|April 11, 2022
A Genome-Wide CRISPR Activation Screen Identifies PRRX2 as a Regulator of Enzalutamide Resistance in Prostate CancerYara Rodríguez, Kenji Unno, Mihai I Truica, et al.Cancer Research|July 3, 2024
Asparagine Dependency Is a Targetable Metabolic Vulnerability in TP53-Altered Castration-Resistant Prostate CancerYoung A Yoo, Songhua Quan, William Yang, et al.Cancer|July 27, 2023
Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B-lineage acute lymphoblastic leukemia: A report of 1021 patients from IndiaDikshat Gopal Gupta, Neelam Varma, Praveen Sharma, et al.Cancer Cell|November 5, 2019
Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance ImmunotherapyHuiying Han, Atul D Jain, Mihai I Truica, et al.Pageof 2